| Pharmaceutical active ingredients: |
| Coagulation Factor HumanVon Willebrand Factor Human |
| Available forms, composition and doses of Humate-P: |
| Injectable; Injection; Antihemophilic Factor Human 1,200 units; Von Willebrand Factor Human 3,360 units / 15 mlInjectable; Injection; Antihemophilic Factor Human 300 units; Von Willebrand Factor Human 840 units / 5 mlInjectable; Injection; Antihemophilic Factor Human 600 units; Von Willebrand Factor Human 1,680 units / 10 ml |
| Humate-P medical category: |
| Human:Hemostatics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| B02BD06 - Von Willebrand Factor and Coagulation Factor VIII in combination |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Sanofi-AventisCSL |